InsidersTradesSigma
Follow the 네이처셀 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 네이처셀 has published 1 insider filings. Market capitalisation: €1,607.7bn. The latest transaction was reported on 20 March 2026 (Purchase). Among the most active insiders: 라정찬. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
네이처셀 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of cell therapies and biopharmaceutical products.